WallStreetZenWallStreetZen

AnalystsMara Goldstein
Mara Goldstein's Stock Forecasts

Analyst Ranking
Top 20%
#883 out of 4527 analysts
Average Return
+11.1%
Win Rate
50%21 out of 42
Risk vs Reward
Poor
Good

Mara Goldstein's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Fate Therapeutics IncFATE
+383.57%$19.36$93.62
2019-12-30 -
2020-12-30
Strong Buy
Fate Therapeutics IncFATE
+182.31%$2.60$7.34
2023-11-20 -
2024-03-27
Strong Buy
Forty Seven IncFTSV
+172.63%$34.66$94.48
2019-12-10 -
2020-03-04
Strong Buy
Iovance Biotherapeutics IncIOVA
+167.55%$5.27$14.10
2023-09-15 -
2024-03-27
Strong Buy
Autolus Therapeutics PLCAUTL
+164.22%$2.04$5.39
2023-03-08 -
2024-03-07
Strong Buy

Mara Goldstein Analyst Color

Get additional color on Mara Goldstein's coverage of popular stocks

Mara Goldstein's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Arcus Biosciences IncRCUS
4Strong Buy$42.00+130.64%Maintains
2 months ago
Xencor IncXNCR
2Strong Buy$50.00+123.02%Maintains
2 months ago
Syndax Pharmaceuticals IncSNDX
1Strong Buy$45.00+95.06%Initiates Coverage On
3 months ago
Kura Oncology IncKURA
1Strong Buy$26.00+22.82%Initiates Coverage On
3 months ago
Incyte CorpINCY
4Hold$77.00+34.80%Maintains
3 months ago
Erasca IncERAS
3Strong Buy$7.00+239.81%Maintains
4 months ago
Fate Therapeutics IncFATE
3Strong Buy$8.00+8.99%Maintains
4 months ago
Leap Therapeutics IncLPTX
5Strong Buy$12.00+331.65%Maintains
4 months ago
Iovance Biotherapeutics IncIOVA
4Strong Buy$30.00+112.77%Reiterates
6 months ago
Verastem IncVSTM
5Strong Buy$36.00+204.57%Reiterates
7 months ago
Nektar TherapeuticsNKTR
3Hold$6.00+577.97%Reiterates
8 months ago
Corvus Pharmaceuticals IncCRVS
4Hold$3.50+95.53%Reiterates
9 months ago
Neurogene IncNGNE
3Hold$7.50-84.77%Maintains
a year ago
In8bio IncINAB
2Strong Buy$12.00+891.74%Reiterates
a year ago
Immuneering CorpIMRX
2Strong Buy$20.00+723.05%Upgrades
a year ago
Merck & Co IncMRK
2Strong Buy$130.00-1.33%Reiterates
a year ago
Cytomx Therapeutics IncCTMX
3Hold$2.00N/AMaintains
a year ago
Tcr2 Therapeutics IncTCRR
1Hold$1.72N/ADowngrades
a year ago
Autolus Therapeutics PLCAUTL
2Strong Buy$12.00N/AMaintains
a year ago
Adaptimmune Therapeutics PLCADAP
2Strong Buy$9.00N/AUpgrades
a year ago
Effector Therapeutics IncEFTR
1Strong Buy$500.00N/AInitiates Coverage On
2 years ago
Kadmon Holdings IncKDMN
1Hold$9.50N/ADowngrades
3 years ago
Forty Seven IncFTSV
2Hold$95.50N/ADowngrades
4 years ago
Array Technologies IncARRY
3Strong Buy$30.00N/AInitiates Coverage On
5 years ago
Cytokinetics IncCYTK
1Strong Buy$14.00N/AInitiates Coverage On
6 years ago
Celldex Therapeutics IncCLDX
1Hold$45.00N/AMaintains
6 years ago
Ayala Pharmaceuticals IncADXS
1Strong Buy$6,000.00N/AMaintains
6 years ago
Ardelyx IncARDX
1Strong Buy$14.00N/AMaintains
6 years ago
Applied Genetic Technologies CorpAGTC
1Hold$9.00N/AMaintains
7 years ago
Progenics Pharmaceuticals IncPGNX
1Strong Buy$15.00N/AInitiates Coverage On
7 years ago
Oncomed Pharmaceuticals IncOMED
1Hold$6.00N/ADowngrades
7 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.